Ureteral Stents Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 6.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Ureteral Stents Market Analysis
The ureteral stent market is expected to record a CAGR of 6.1% over the forecast period (2022-2027).
COVID-19 had a notable impact on the overall healthcare industry. As per the article published in 2020 under the title 'Urinary stone management during the COVID-19 pandemic: a suggested approach and review of literature', the study suggested that at-risk patients should be evaluated for urinary stones with ultrasonography after the lockdown period. The prolonged homestay has several negative effects on patients, including weight gain and physical inactivity, which may increase their chance of developing kidney stones. Furthermore, the article published in 2021 under the title 'Challenges in Urology during the COVID-19 Pandemic', stated that the issue of renal injury in COVID-19 patients needs a lot of attention since the chance of fluctuations in blood components is likely to be higher compared to other patients. Hence as per the factors mentioned above, COVID-19 had a significant impact on the ureteral stent market.
According to the American Urological Association, the most prevalent urological conditions are benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), and ureteral stones. As per the same source, the average number of practicing urologists in the United States was 13,790 in 2021. Increased awareness, research and development, and government-funded programs related to the studies field boost market growth. For instance, the National Institute of Diabetes and Digestive and Kidney Diseases celebrated national kidney month in March 2022. The source states that NIDDK raises awareness and focuses on building paths to better kidney care.
As per the aforementioned factors, the ureteral stent market is likely to grow over the forecast period. However, the risk of infection restrains the market growth.
Ureteral Stents Market Trends
This section covers the major market trends shaping the Ureteral Stents Market according to our research experts:
Urinary Tract Infection Segment is Expected to Exibhit a Significant Growth Rate in the Ureteral Stent Market
The urinary tract infection segment is expected to exhibit significant growth in the ureteral stents market, owing to a higher incidence of urinary tract infection, kidney and bladder diseases, and higher adoption of ureteral stents. For instance, as per International Agency for Research on Cancer, the estimated number of people with bladder cancer is likely to be 7,356,11 by 2030. Furthermore, as per the same source, the mortality relating to bladder cancer is expected to be 2,861,64 by 2030. Since the anticipated number of cancers relating to the bladder is higher there is likely to be more adoption of ureteral stents and thus boosting the market growth.
The presence of competitors, research initiatives, and government funding fuels market growth. For instance, an article published in 2022 under the title 'Allium Ureteral Stent as a Treatment for Ureteral Stricture: Results and Concerns', stated that 'Allium URS' is likely to be considered a feasible and attractive treatment of ureteral strictures, due to its minimal invasiveness and it is best suited for the older population.
Because of the aforementioned factors, the total urinary tract infection segment is likely to face growth over the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major market share in the global ureteral stent market due to the growing burden of diseases related to the kidney. According to the Center for Disease Control and Prevention data in 2021, in the United States, nearly 1 in 3 people with diabetes and 1 in 5 people with high blood pressure have kidney disease. Furthermore, despite the prevalence of kidney disease in the United States, as many as 9 in 10 people who have CKD are not aware they have the disease. Thus, the rising prevalence of chronic kidney disease is expected to be a major contributor to the ureteral stents market in this region.
Increased research and development in the field of ureteral stent boost the market growth. For instance, an article published in 2022 under the title 'Design of a fully intraureteral stent and proof-of-concept in vivo evaluation', special focus has been given to new coated and biodegradable ureteral stent designs. To lessen tissue irritation, these stents work to decrease inflammatory processes and microbial adherence to the stent.
As per the factors mentioned above, North America is expected to witness growth over the forecast period.
Ureteral Stents Industry Overview
Companies have been taking strategic initiatives such as collaborations, mergers, and acquisitions, which is expected to drive the market growth. Some of the companies, which are currently dominating the market are Uromed, Allium Medical, Coloplast, Beckton, Dickinson, and Company, Boston Scientific, Olympus Corporation, Cook Medical, and B. Braun SE.
Ureteral Stents Market Leaders
Boston Scientific
Teleflex Inc.
Beckton, Dickinson and Company
B. Braun SE
Olympus Corporation
*Disclaimer: Major Players sorted in no particular order
Ureteral Stents Market News
- In June 2022, Boston Scientific has been recognized with a Bronze Edison Award in the Science and Medical category for its Tria Ureteral Stent, the first stent made with a proprietary surface technology designed to provide protection against the accumulation of both urine calcium and magnesium salt deposits.
- In May 2022, The United States Food and Drug Administration granted 510k clearance for a novel urinary stent developed by Dean Secrest and Lee Ponsky, MD, Chair of the Department of Urology and Leo and Charlotte Goldberg, Chair in Advanced Surgical Therapies at University Hospitals (UH) in Cleveland.
Ureteral Stents Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Urological Disorders
4.2.2 Awarness Campaigns Initiated by Government and Other Organization
4.3 Market Restraints
4.3.1 Risk of Infection
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
5.1 By Product Type
5.1.1 Open-Ended
5.1.2 Close-Ended
5.1.3 Double Pigtail
5.1.4 Multiloop
5.2 By Application
5.2.1 Kidney Stones
5.2.2 Kidney Transplant
5.2.3 Urinary Tract Infection
5.2.4 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Rest of the World
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allium Medical
6.1.2 Becton, Dickinson and Company (C.R. Bard)
6.1.3 B.Braun
6.1.4 Boston Scientific
6.1.5 Coloplast
6.1.6 Cook Medical
6.1.7 Olympus America
6.1.8 Teleflex Inc.
6.1.9 Uromed
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Ureteral Stents Industry Segmentation
As per the scope of the report, ureteral stents are tubes that are usually placed in the ureter to prevent blockage and allow passage for urine flow from the kidney to the urinary bladder. The Ureteral Stent Market is segmented by Product Type (Open-Ended, Close Ended, Double Pigtail, and Multiloop), Application (Kidney Stones, Kidney Transplant, Urinary Tract Infection, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Product Type | |
| Open-Ended | |
| Close-Ended | |
| Double Pigtail | |
| Multiloop |
| By Application | |
| Kidney Stones | |
| Kidney Transplant | |
| Urinary Tract Infection | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of the World |
Ureteral Stents Market Research FAQs
What is the current Global Ureteral Stent Market size?
The Global Ureteral Stent Market is projected to register a CAGR of 6.10% during the forecast period (2024-2029)
Who are the key players in Global Ureteral Stent Market?
Boston Scientific, Teleflex Inc., Beckton, Dickinson and Company, B. Braun SE and Olympus Corporation are the major companies operating in the Global Ureteral Stent Market.
Which is the fastest growing region in Global Ureteral Stent Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Ureteral Stent Market?
In 2024, the North America accounts for the largest market share in Global Ureteral Stent Market.
What years does this Global Ureteral Stent Market cover?
The report covers the Global Ureteral Stent Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Ureteral Stent Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Ureteral Stents Industry Report
Statistics for the 2023 Ureteral Stents market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Ureteral Stents analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
